Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
ReportsAn Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
FtsZ is an essential bacterial guanosine triphosphatase and homolog of mammalian β-tubulin that polymerizes and assembles into a ring to initiate cell division. We have created a class of small synthetic antibacterials, exemplified by PC190723, which inhibits FtsZ and prevents cell division. PC190723 has potent and selective in vitro bactericidal activity against staphylococci, including methicillin- and multi-drug–resistant Staphylococcus aureus. The putative inhibitor-binding site of PC190723 was mapped to a region of FtsZ that is analogous to the Taxol-binding site of tubulin. PC190723 was efficacious in an in vivo model of infection, curing mice infected with a lethal dose of S. aureus. The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti-staphylococcal therapy.
1 Prolysis, Begbroke Science Park, Oxfordshire OX5 1PF, UK.
2 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, UK. 3 Prosarix, Newton Hall, Cambridge CB22 7ZE, UK. 4 Jubilant Chemsys, B-34, Sector-58, Noida 201301, India. 5 Institute for Cell and Molecular Biosciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. * To whom correspondence should be addressed. E-mail: neil.stokes{at}prolysis.com
The editors suggest the following Related Resources on Science sites:In Science Magazine
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)